William Lapps, Jr., PhD Merck & Co., Inc.

William Lapps, Ph.D. is the Director and Global Regulatory Liaison at Merck for the Ebola Zaire Vaccine, Live, ERVEBOâ„¢. His experience includes more than 21 years in vaccine regulatory affairs primarily supporting development and life cycle management of viral vaccines. Bill has contributed as a Global Regulatory Team Leader on various vaccine programs, including influenza vaccines, live attenuated and recombinant vaccines, inactivated vaccines, recombinant proteins and adjuvants. He led a team to license a Quadrivalent Influenza Vaccine in the United States and internationally, in addition to working on an Adjuvanted Pandemic Influenza Vaccine in collaboration with the United States Biomedical Advanced Research and Development Authority. Bill developed and led strategic communications with worldwide Health Authorities for development and license maintenance. He developed and implemented both clinical and CMC regulatory strategies. Bill received his B.A. in Biology from Temple University in Philadelphia, and his Ph.D. in Microbiology from the University of Tennessee. He performed a post-doctoral fellowship in Molecular Genetics at the Roche Research Center in Nutley, NJ.